Lykos Therapeutics
Business Services · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
3141 Stevens Crk 40547, San Jose, Califo...Website
www.lykospbc.comRevenue
$42.7 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
2
1
1
1
About Lykos Therapeutics
At Lykos, formerly MAPS PBC, our mission is to transform mental health care. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain committed to the rigorous pursuit of evidence-based development of novel approaches. Founded in 2014 by the non-profit MAPS, Lykos Therapeutics is a for-profit public benefit corporation ("PBC") established to further the development of investigational psychedelic-assisted therapies. As a PBC, we consider the impact of our decisions on society just as we think about financial implications. Everything we do is viewed through a public benefit lens.Explore more
Lykos Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lykos Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Lykos Therapeutics
Earning: See what the market has to say on Lykos Therapeutics recently announced quarterly report
Check if Lykos Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Lykos Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Lykos Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Lykos Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Lykos Therapeutics has new funding data
Product Launch: Get notified when Lykos Therapeutics launches new products
Recommended Actions
Find VP level buyers at Lykos Therapeutics
Find 3 more new buyers
Company Profile Activity
Activity Insights
Lykos Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Lykos Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Lykos Therapeutics.
Lykos Therapeutics financials insights
Gather financial insights about Lykos Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$100M
Lykos Therapeutics Tech Stack
A closer look at the technologies used by Lykos Therapeutics
Most Recent Scoops
Executive Move
Michael Mullette, Interim Chief Executive Officer for Lykos Therapeutics, has been nominated to the Board of Directors for Dynavax Technologies.
Executive Moves, Board of Directors
Person-Based
Person-Based
Left Company
Executive Move
Executive Moves, Left Company
Left Company
Executive Move
Executive Moves, Left Company
Lykos Therapeutics News & Media
Lykos Therapeutics Reshuffles Board of Directors Following FDA Rejection of ...
During the transition period, Lykos will work with a number of shareholders to secure financing for an additional Phase III trial of midomafetamine capsules for post-traumatic stress disorder.Lykos Therapeutics Announces Appointments of Michael Mullette as Interim Chief Executive Officer and Dr. David Hough as Chief Medical Officer
Amy Emerson, Lykos' founding leader, stepping down as CEO Pharma veteran and Lykos Chief Operating Officer Michael Mullette appointed as interim CEO Dr. David Hough named Chief Medical Officer SAN JOSE, Calif., Sept. 5, 2024 /PRNewswire/ -- Lykos Therapeutics ("Lykos"), a company...Lykos to lay off 75% of workforce in wake of PTSD drug rejection - Becker's Hospital Review
"Lykos Therapeutics to reduce workforce by 75% after FDA rejects MDMA for PTSD treatment. Remaining team to focus on clinical development and FDA engagement, le
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lykos Therapeutics
Sign Up For FreeTo access detailed company insights
At Lykos, formerly MAPS PBC, our mission is to transform mental health care. We aspire to challenge the status quo through the development of novel therapies and therapeutic approaches to treat mental health conditions. With 30+ years of experience researching psychedelic-assisted therapies, we remain committed to the rigorous pursuit of evidence-b... Read More
